The life sciences industry has long been at the forefront of innovation, and 2025 promises to continue this trajectory with exciting developments in intellectual property (IP), licensing, and mergers and acquisitions (M&A)....more
1/20/2025
/ Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Data Protection ,
Innovation ,
Intellectual Property Protection ,
IP License ,
Life Sciences ,
Machine Learning ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Popular
At a time marked by themes of “push” and “pull,” organizations across all sectors and jurisdictions are grappling with the pursuit of innovation within an increasingly complex regulatory framework. Over the next 12 months,...more